Author

D. R. Morris

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 5

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Research Focus:host-pathogen & immune response· 4 Organism:mouse· 3 Organism:bacteria (other)· 1 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

V. D. Menachery· 3 shared A. Casola· 2 shared A. Haas de Mello· 2 shared D. H. Walker· 2 shared J. A. Plante· 2 shared M. N. Vu· 2 shared R. E. Alvarado· 2 shared R. P. Garofalo· 2 shared

Activity by Year

2019-2023 · peak 4/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

V. D. Menachery

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

SARS-CoV-2 hijacks fragile X mental retardation proteins for efficient infection

D. Garvanska, R. E. Alvarado, F. Mundt, E. Nilsson, J. Duel, F. Coscia, R. Lindqvist, K. Lokugamage, B. Johnson, J. A. Plante, D. R. Morris, M. N. Vu, L. Estes, A. McLeland, J. Walker, , J. Nilsson

This study identifies a novel interaction between SARS-CoV-2 NSP3 and FMRPs, showing that this interaction is critical for viral replication and disease progression.

bioRxiv · Sep 1, 2023 · PreprintMicrobiology

Hypoxia-inducible-factors differentially contribute to clinical disease and the control of viral replication during RSV infection

D. R. Morris, Y. Qu, A. Haas de Mello, Y. L. Jones-Hall, T. Liu, M. Weglarz, T. Ivanciuc, R. P. Garofalo, A. Casola

This study investigates the differential roles of HIF-1 and HIF-2 inhibitors in RSV infection, finding that HIF-1 inhibition worsens disease but reduces viral replication, while HIF-2 inhibition improves clinical outcomes and reduces viral load.

bioRxiv · Aug 15, 2023 · PreprintMicrobiology

The impact of RSV/SARS-CoV-2 co-infection on clinical disease and viral replication: insights from a BALB/c mouse model

D. R. Morris, Y. Qu, K. S. Thomason, A. Haas de Mello, R. Preble, V. D. Menachery, A. Casola, R. P. Garofalo

This study investigates how RSV and SARS-CoV-2 co-infection affects clinical disease and viral replication in mice, finding that infection timing and viral dose influence disease outcomes.

bioRxiv · May 24, 2023 · PreprintMicrobiology

Loss-of-function mutation in Omicron variants reduces spike protein expression and attenuates SARS-CoV-2 infection

M. N. Vu, R. E. Alvarado, D. R. Morris, K. G. Lokugamage, Y. Zhou, A. L. Morgan, L. K. Estes, A. M. McLeland, C. Schindewolf, J. A. Plante, Y. P. Ahearn, W. M. Meyers, J. T. Murray, S. Weaver, D. H. Walker, , V. D. Menachery

This study identifies the N679K mutation in Omicron variants as reducing spike protein expression and attenuating SARS-CoV-2 infection, while showing a replication advantage in the upper airway.

bioRxiv · Apr 17, 2023Microbiology

Bacterial longevity requires protein synthesis and a stringent response

L. Yin, H. Ma, E. S. Nakayasu, S. H. Payne, D. R. Morris, C. S. Harwood

This study shows that protein synthesis and a stringent response are required for bacterial longevity during growth arrest in Rhodopseudomonas palustris.

bioRxiv · Aug 28, 2019Microbiology